- Report
- December 2022
- 141 Pages
Europe
From €3189EUR$3,450USD£2,688GBP
- Report
- December 2022
- 141 Pages
Asia Pacific
From €3189EUR$3,450USD£2,688GBP
- Report
- August 2022
- 200 Pages
Global
From €4113EUR$4,450USD£3,467GBP
- Report
- March 2022
- 217 Pages
Global
From €4113EUR$4,450USD£3,467GBP
- Report
- April 2024
- 106 Pages
Asia Pacific
From €3189EUR$3,450USD£2,688GBP
- Report
- April 2024
- 96 Pages
North America
From €3189EUR$3,450USD£2,688GBP
- Report
- January 2023
- 145 Pages
Europe
From €3189EUR$3,450USD£2,688GBP
- Report
- January 2023
- 140 Pages
Middle East, Africa
From €3189EUR$3,450USD£2,688GBP
- Report
- June 2022
- 120 Pages
Global
From €2311EUR$2,500USD£1,948GBP
- Report
- October 2023
- 172 Pages
Global
From €2311EUR$2,500USD£1,948GBP
- Report
- December 2024
- 80 Pages
India
From €3235EUR$3,500USD£2,727GBP
- Report
- February 2024
- 186 Pages
Global
From €4159EUR$4,500USD£3,506GBP
- Report
- October 2023
- 172 Pages
Global
From €4159EUR$4,500USD£3,506GBP
- Report
- July 2024
- 110 Pages
From €4390EUR$4,750USD£3,701GBP
- Report
- April 2023
- 120 Pages
Global
From €4390EUR$4,750USD£3,701GBP
- Report
- February 2024
- 114 Pages
Global
From €4390EUR$4,750USD£3,701GBP
- Report
- February 2024
- 115 Pages
Global
From €4390EUR$4,750USD£3,701GBP
- Report
- February 2024
- 130 Pages
Global
From €4390EUR$4,750USD£3,701GBP
- Report
- February 2024
- 114 Pages
Global
From €4390EUR$4,750USD£3,701GBP
- Report
- August 2023
- 70 Pages
Latin America
From €4390EUR$4,750USD£3,701GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more